Pathogen-like Nanoassemblies of Covalently Linked TLR Agonists Enhance CD8 and NK Cell-Mediated Antitumor Immunity

[Image: see text] Therapies based on Toll Like Receptor agonists (TLRa) are emerging as a promising modality for cancer immunotherapy to recruit antitumor T-cells in unresponsive immunologically “cold” tumors. Often, combinations of agonists are employed to synergistically enhance efficacy. However,...

Descripción completa

Detalles Bibliográficos
Autores principales: Manna, Saikat, Maiti, Sampa, Shen, Jingjing, Du, Wenjun, Esser-Kahn, Aaron P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Chemical Society 2020
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7706081/
https://www.ncbi.nlm.nih.gov/pubmed/33274283
http://dx.doi.org/10.1021/acscentsci.0c01001

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7706081/
https://www.ncbi.nlm.nih.gov/pubmed/33274283
http://dx.doi.org/10.1021/acscentsci.0c01001

Ejemplares similares